Market Cap 26.01M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 70,700
Avg Vol 218,228
Day's Range N/A - N/A
Shares Out 8.70M
Stochastic %K 69%
Beta 1.21
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
ColeCapInvests
ColeCapInvests Jun. 25 at 4:46 PM
$BCTX I forgot to mention another wonderful smell of BO with this Save the Big Stocktwitties Immunotherapy Juggs-er-nuts! They are waiting for death events to occur which are delayed just like $SLS !! Plus she’s a Low Floater on top of saving her Stocktitties! #Suckem Cancer
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 4:42 PM
$BCTX taking steps beyond the clinic. Partnering with Uneedle - Xtremepicks Alerts https://investorshangout.com/post/view?id=6835321
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 4:20 PM
BLUE SKY BREAKOUT : $BCTX BriaCell partners with Uneedle to... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177733904 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 3:52 PM
$BCTX BriaCell partners with Uneedle to scale microneedle delivery of Bria‑IMT — supporting faster, more convenient intradermal dosing in its Phase 3 study. Details: https://wix.to/UEVYQWI #Biotech #ClinicalTrials #BriaCell
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 3:48 PM
$BCTX BriaCell partners with Uneedle to scale microneedle delivery of Bria‑IMT — supporting faster, more convenient intradermal dosing in its Phase 3 study. Details: https://wix.to/UEVYQWI #Biotech #ClinicalTrials #BriaCell
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 3:35 PM
MOMO'S BREAKOUT BOARD : $BCTX taking steps beyond the clinic.... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177733661 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 3:00 PM
$BCTX taking steps beyond the clinic. Partnering with Uneedle to scale proprietary microneedle tech used in its Phase 3 trial. Faster, more convenient dosing and improved patient experience. Commercial strategy starting to take shape. NEWS: https://bit.ly/4v2fzJ3
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 2:48 PM
New partnership for $BCTX 👇 BriaCell signs MoU with Uneedle to support commercial-scale microneedle delivery of Bria-IMT (Phase 3 breast cancer). Keys to watch: • Regulatory path • Manufacturing scale-up • Patient-friendly delivery edge NEWS: https://bit.ly/4v2fzJ3
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 2:46 PM
BriaCell Therapeutics Corp ( $BCTX ): $BCTX partnered with Uneedle to scale mi... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177733550 via @Investors_Hub @smallcapvoice
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 2:44 PM
$BCTX BriaCell partners with Uneedle to scale microneedle delivery of Bria-IMT — aiming for faster, more convenient intradermal administration as used in the Phase 3 study. Full story: https://wix.to/6WXUKDd #Biotech #Oncology #MedTech
0 · Reply
Latest News on BCTX
BriaCell enters MoU with Uneedle for microneedle technology

2026-06-25T11:45:30.000Z - 5 hours ago

BriaCell enters MoU with Uneedle for microneedle technology


BriaCell Therapeutics Announces Closing of Offering

Tue, 02 Jun 2026 16:05:00 -0400 - 22 days ago

BriaCell Therapeutics Announces Closing of Offering


BriaCell Presents Positive Clinical Data at ASCO 2026

Mon, 01 Jun 2026 07:30:00 -0400 - 24 days ago

BriaCell Presents Positive Clinical Data at ASCO 2026


BriaCell Therapeutics Announces Pricing of Offering

Sun, 31 May 2026 19:59:00 -0400 - 24 days ago

BriaCell Therapeutics Announces Pricing of Offering


BriaCell announces data from Bria-IMT at ASCO 2026

2026-05-22T11:49:02.000Z - 4 weeks ago

BriaCell announces data from Bria-IMT at ASCO 2026


BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Tue, 12 May 2026 07:30:00 -0400 - 6 weeks ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients


BriaCell receives FDA clearance to initiate Bria-BRES+ trial

2026-05-07T04:03:56.000Z - 7 weeks ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial


BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Mon, 27 Apr 2026 07:30:00 -0400 - 2 months ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026


BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T13:28:43.000Z - 2 months ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting


BriaCell presents anti-cancer activity of Bria-OTS

2026-04-21T11:54:23.000Z - 2 months ago

BriaCell presents anti-cancer activity of Bria-OTS


BriaCell to present four posters at the 2026 AACR

2026-03-18T11:42:55.000Z - 3 months ago

BriaCell to present four posters at the 2026 AACR


BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 3 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting


BriaCell (BCTX) Reports Promising Phase 2 Survival Data

2026-01-27T13:32:37.000Z - 5 months ago

BriaCell (BCTX) Reports Promising Phase 2 Survival Data


Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

2026-01-19T16:00:45.000Z - 5 months ago

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?


BriaCell Therapeutics Announces Closing of US$30 million Public Offering

Thu, 15 Jan 2026 16:05:00 -0500 - 5 months ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering


What's Going On With BriaCell Therapeutics Stock Wednesday?

2026-01-14T11:36:30.000Z - 5 months ago

What's Going On With BriaCell Therapeutics Stock Wednesday?


BriaCell Therapeutics trading resumes

2026-01-13T14:41:11.000Z - 5 months ago

BriaCell Therapeutics trading resumes


BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T14:35:29.000Z - 5 months ago

BriaCell Therapeutics trading halted, volatility trading pause


BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 8 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025


BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 21, 2025, 12:00 PM EDT - 11 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation


BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 30, 2025, 7:30 AM EDT - 11 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology


ColeCapInvests
ColeCapInvests Jun. 25 at 4:46 PM
$BCTX I forgot to mention another wonderful smell of BO with this Save the Big Stocktwitties Immunotherapy Juggs-er-nuts! They are waiting for death events to occur which are delayed just like $SLS !! Plus she’s a Low Floater on top of saving her Stocktitties! #Suckem Cancer
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 4:42 PM
$BCTX taking steps beyond the clinic. Partnering with Uneedle - Xtremepicks Alerts https://investorshangout.com/post/view?id=6835321
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 4:20 PM
BLUE SKY BREAKOUT : $BCTX BriaCell partners with Uneedle to... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177733904 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 3:52 PM
$BCTX BriaCell partners with Uneedle to scale microneedle delivery of Bria‑IMT — supporting faster, more convenient intradermal dosing in its Phase 3 study. Details: https://wix.to/UEVYQWI #Biotech #ClinicalTrials #BriaCell
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 3:48 PM
$BCTX BriaCell partners with Uneedle to scale microneedle delivery of Bria‑IMT — supporting faster, more convenient intradermal dosing in its Phase 3 study. Details: https://wix.to/UEVYQWI #Biotech #ClinicalTrials #BriaCell
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 3:35 PM
MOMO'S BREAKOUT BOARD : $BCTX taking steps beyond the clinic.... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177733661 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 3:00 PM
$BCTX taking steps beyond the clinic. Partnering with Uneedle to scale proprietary microneedle tech used in its Phase 3 trial. Faster, more convenient dosing and improved patient experience. Commercial strategy starting to take shape. NEWS: https://bit.ly/4v2fzJ3
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 2:48 PM
New partnership for $BCTX 👇 BriaCell signs MoU with Uneedle to support commercial-scale microneedle delivery of Bria-IMT (Phase 3 breast cancer). Keys to watch: • Regulatory path • Manufacturing scale-up • Patient-friendly delivery edge NEWS: https://bit.ly/4v2fzJ3
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 2:46 PM
BriaCell Therapeutics Corp ( $BCTX ): $BCTX partnered with Uneedle to scale mi... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177733550 via @Investors_Hub @smallcapvoice
0 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 25 at 2:44 PM
$BCTX BriaCell partners with Uneedle to scale microneedle delivery of Bria-IMT — aiming for faster, more convenient intradermal administration as used in the Phase 3 study. Full story: https://wix.to/6WXUKDd #Biotech #Oncology #MedTech
0 · Reply
BHWinehouse
BHWinehouse Jun. 25 at 2:27 PM
$BCTX Today @ 2:00 EST
0 · Reply
JediGreen
JediGreen Jun. 25 at 1:24 PM
0 · Reply
Kirubin
Kirubin Jun. 25 at 12:38 PM
$BCTX now this is worthy of news! Pathetic!
0 · Reply
RafaSantos
RafaSantos Jun. 25 at 12:31 PM
$BCTX Excellent news https://feeds.issuerdirect.com/news-release.html?newsid=4583956826476124&symbol=BCTX
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Jun. 25 at 11:56 AM
$BCTX So gross, total sleazeball marketers…. What next, tattooing “Pepsi” on women’s breasts.
0 · Reply
focafoca99
focafoca99 Jun. 25 at 11:48 AM
$BCTX signed a MoU with Uneedle to scale microneedle delivery of its Bria-IMT cancer therapy.
0 · Reply
SmallCapVoice
SmallCapVoice Jun. 25 at 11:46 AM
BriaCell $BCTX partners with Uneedle to support scalable microneedle administration of Bria-IMT, helping advance commercial readiness for its lead Phase 3 candidate in metastatic breast cancer. The technology is already being used in the pivotal study to support faster, more convenient intradermal delivery. https://www.globenewswire.com/news-release/2026/06/25/3317432/0/en/briacell-partners-with-uneedle-for-scalable-microneedle-administration-of-bria-imt.html
0 · Reply
bobwut12
bobwut12 Jun. 25 at 2:46 AM
$MDNAF Here's a depressing fact I just noticed, we've done worse YTD than even Briacell ($BCTX ). Canadian biotech penny stocks are rough - I've had multiple go to $0 - hopefully that doesn't happen here
1 · Reply
BHWinehouse
BHWinehouse Jun. 24 at 12:13 PM
$BCTX At this point in the trial, tomorrow's roadshow could prove to be very interesting: https://www.renmarkfinancial.com/events/renmark-virtual-non-deal-roadshow-tsx-bct-nasdaq-bctx-8VceUWksMG
2 · Reply
Mateuszrozek
Mateuszrozek Jun. 24 at 8:35 AM
$BCTX what’s going on??
2 · Reply
Ares77manoe
Ares77manoe Jun. 22 at 1:49 PM
0 · Reply
TWBXX
TWBXX Jun. 21 at 5:05 PM
$BCTX Does a long trial automatically mean Phase 3 > Phase 2? Not automatically — but probabilistically, yes. Here’s why: Phase 2 OS = 16.6 months This was in heavily pretreated, late‑line metastatic breast cancer. Phase 3 patients are earlier‑line Earlier‑line patients always live longer. If Phase 3 OS were worse than Phase 2, the event count would have hit 140 much earlier, not later. If Phase 3 OS were equal to Phase 2, the event count would have hit 140 roughly on schedule. If Phase 3 OS is better than Phase 2, the event count is delayed — exactly what we’re seeing.
2 · Reply